Related Experiment Videos

[Overdose of methotrexate with a fatal outcome in a patient with rheumatoid arthritis]

W Porawska1

  • 1Kliniki Reumatologii Instytutu Chorób Wewnetrznych Akademii Medycznej w Poznaniu.

Insights

Methotrexate (MTX) overdose in a rheumatoid arthritis patient caused severe oral, skin, and gastrointestinal issues, leading to fatal pneumonia and mycosis. This case highlights MTX toxicity risks.

Area of Science:

  • Toxicology
  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) management often involves methotrexate (MTX).
  • MTX is a potent disease-modifying antirheumatic drug (DMARD).
  • Accidental overdose can lead to severe adverse events.

Observation:

  • A 52-year-old female RA patient mistakenly took 112.5 mg MTX daily for five days.
  • Observed extensive oral, groin, and vulvar mucous membrane erosions and necrosis.
  • Symptoms included GI hemorrhages, dermal xanthochromia, interstitial pneumonia, renal insufficiency, and hair loss.

Findings:

  • Laboratory results revealed agranulocytosis, thrombocytopenia, anemia, elevated transaminases and bilirubin, and megakaryocyte deficiency.
  • Dermal cultures initially showed bacterial growth, followed by Candida albicans.
  • The patient succumbed to pneumonia and extensive mycosis on day 22 post-overdose.

Implications:

  • This case underscores the critical importance of accurate methotrexate dosing.
  • Highlights the potential for severe, multi-organ toxicity with MTX overdose.
  • Emphasizes the need for prompt recognition and management of MTX toxicity in clinical practice.

Related Concept Videos